Abstract:NLRP3 inflammasome is activated by proatherogenic stimulations to result in vascular injury, inflammation, and ultimately atherosclerosis. It remains unknown how this inflammasome activation is endogenously regulated during atherogenesis. The present study hypothesized that autophagy and associated lysosome function serve as a critical modulator in NLRP3 inflammasome activation upon proatherogeneic stimuli. We first detected inflammasome activation in isolated and cultured mouse coronary arterial smooth muscle cells (CASMCs) from wild type (CD38 +/+ ) mice and mice with deletion of CD38 gene (CD38 −/− ), a gene encoding ADP‐ribosylcyclase that regulates lysosome function and autophagic flux. Western blot analysis showed that cleaved caspase‐1 was much higher in CASMCs from CD38 −/− than CD38 +/+ mice, and that increased active caspase‐1 led to enhanced IL‐1β release to the cell culture media. In animal experiments, we found increased colocalization of NLRP3 vs ASC or vs Casp‐1 as well as enhanced IL‐1β accumulation in the coronary arterial wall in CD38 −/− mice on the Western diet (WD) compared to CD38 +/+ mice. This WD‐induced NRLP3 inflammasome formation and activation could be blocked by treatment of rapamycin, an autophagy enhancer. However, chloroquine, a lysosme function inhibitor and blocker of autophagic flux, markedly enhanced WD‐induced NRLP3 inflammasome formation and activation. Morphological examinations confirmed that the media of coronary arteries was significantly thicker in CD38 −/− mice on the WD than CD38 +/+ mice. This WD‐induced coronary arterial thickening was completely blocked by treatment of mice with rapamycin but enhanced by chloroquine. In conclusion, deficiency of autophagic flux due to CD38 gene deletion promotes NLRP3 inflammasome formation and activation in CASMCs, and rapamycin‐induced autophagy reverses the effects of proatherogeneic stimulation via inhibition of the NLRP3 inflammasome. The efficient autophagy is essential in the control of NLRP3 inflamamsome activation preventing the medial thickening of coronary arteries in response to proatherogenic stimuli. Support or Funding Information Supported by NIH grants HL057244, HL075316 and HL122937

Regulation of NLRP3 inflammasome by CD38 through cADPR-mediated Ca2+ release in vascular smooth muscle cells in diabetic mice

NLRP3 inflammasome links vascular senescence to diabetic vascular lesions

Nlrp3 Gene Silencing Ameliorates Diabetic Cardiomyopathy In A Type 2 Diabetes Rat Model

Protective Role of Autophagy in NLRP3 Inflammasome Activation and Medial Thickening of Mouse Coronary Arteries

CD38 deficiency prevents diabetic nephropathy by inhibiting lipid accumulation and oxidative stress through activation of the SIRT3 pathway

High glucose levels accelerate atherosclerosis via NLRP3-IL/ MAPK/NF-κB-related inflammation pathways

CD38 Deficiency Alleviates Diabetic Cardiomyopathy by Coordinately Inhibiting Pyroptosis and Apoptosis

CD38 deficiency alleviates Ang II-induced vascular remodeling by inhibiting small extracellular vesicle-mediated vascular smooth muscle cell senescence in mice

Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy

NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy

Endothelial Nucleotide-Binding Oligomerization Domain-Like Receptor Protein 3 Inflammasome Regulation in Atherosclerosis.

Spleen Tyrosine Kinase‑induced JNK‑dependent NLRP3 Activation is Involved in Diabetic Cardiomyopathy.

NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice.

CD38 inhibition by apigenin ameliorates mitochondrial oxidative stress through restoration of the intracellular NAD+/NADH ratio and Sirt3 activity in renal tubular cells in diabetic rats

Smooth-Muscle-Cell-Specific Deletion of CD38 Protects Mice from AngII-Induced Abdominal Aortic Aneurysm through Inhibiting Vascular Remodeling

CD38 Deficiency Alleviated Angiotensin II-induced Vascular Remodeling Through Activating NAD-mediated Signaling Pathways

Nlrp3 Activation In Endothelia Promotes Development Of Diabetes-Associated Atherosclerosis

Endothelial NLRP3 inflammasome regulation in atherosclerosis

Activation of the NLRP3 inflammasome by RAC1 mediates a new mechanism in diabetic nephropathy

Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes

Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy